X4 Pharmaceuticals, Inc financial data

Symbol
XFOR on Nasdaq
Location
61 North Beacon Street, 4 Th Floor, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 393 % -22.1%
Debt-to-equity 393 % +83.1%
Return On Equity -344 % -957%
Return On Assets -69.8 % -575%
Operating Margin -291 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 87.4M shares -48.7%
Common Stock, Shares, Outstanding 25.1M shares -85.1%
Entity Public Float 96M USD -69.8%
Common Stock, Value, Issued 25K USD -85.1%
Weighted Average Number of Shares Outstanding, Basic 43.3M shares +546%
Weighted Average Number of Shares Outstanding, Diluted 43.3M shares +546%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.57M USD +180%
Revenue from Contract with Customer, Excluding Assessed Tax 34M USD +215%
Cost of Revenue 5.7M USD +54.6%
Research and Development Expense 75.9M USD +0.92%
General and Administrative Expense 51.3M USD -8.92%
Operating Income (Loss) -98.9M USD -282%
Nonoperating Income (Expense) 4.1M USD -55.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -94.8M USD -469%
Income Tax Expense (Benefit) 299K USD +252%
Net Income (Loss) Attributable to Parent -95.1M USD -467%
Earnings Per Share, Basic -4 USD/shares -1822%
Earnings Per Share, Diluted -4 USD/shares -1952%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 69.6M USD -28.5%
Cash, Cash Equivalents, and Short-term Investments 122M USD -9.48%
Accounts Receivable, after Allowance for Credit Loss, Current 891K USD
Inventory, Net 2.82M USD
Assets, Current 133M USD -7.11%
Property, Plant and Equipment, Net 218K USD -73.4%
Operating Lease, Right-of-Use Asset 1.78M USD -60.3%
Goodwill 17.4M USD 0%
Other Assets, Noncurrent 1.97M USD -16.7%
Assets 164M USD -8.2%
Accounts Payable, Current 5.05M USD -41.1%
Employee-related Liabilities, Current 8.34M USD -9.42%
Accrued Liabilities, Current 16.7M USD -14.4%
Contract with Customer, Liability, Current 592K USD
Liabilities, Current 23.5M USD -19.7%
Contract with Customer, Liability, Noncurrent 789K USD
Operating Lease, Liability, Noncurrent 95K USD -94.6%
Other Liabilities, Noncurrent 525K USD -56.9%
Liabilities 102M USD -14%
Accumulated Other Comprehensive Income (Loss), Net of Tax -118K USD -3.51%
Retained Earnings (Accumulated Deficit) -571M USD -20%
Stockholders' Equity Attributable to Parent 61.6M USD +3.35%
Liabilities and Equity 164M USD -8.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.4M USD +63.2%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities -3.14M USD +41%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 25.1M shares -85.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -15.4M USD +60.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 70.4M USD -28.3%
Deferred Tax Assets, Valuation Allowance 185M USD +12.8%
Deferred Tax Assets, Gross 186M USD +12.4%
Operating Lease, Liability 1.3M USD -56.5%
Depreciation 289K USD +366%
Lessee, Operating Lease, Liability, to be Paid 1.39M USD -59.8%
Property, Plant and Equipment, Gross 1.42M USD -44.4%
Operating Lease, Liability, Current 1.2M USD -1.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 306K USD -77%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.05M USD -25.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 91K USD -80.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 51K USD -81.8%
Deferred Tax Assets, Operating Loss Carryforwards 115M USD -6.19%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Unrecognized Tax Benefits 200K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 45K USD -84.4%
Operating Lease, Payments 1.41M USD +2.1%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 0 USD
Amortization of Intangible Assets 200K USD
Depreciation, Depletion and Amortization 476K USD +668%
Deferred Tax Assets, Net of Valuation Allowance 778K USD -31.6%
Share-based Payment Arrangement, Expense 4.24M USD -50.2%
Interest Expense 8.35M USD +65.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares